Table 1.
Comorbidities and sociodemographic characteristics of the study cohort.
| Osteoporosis (OSPO) | Non-Osteoporosis (N-OSPO) | |||
|---|---|---|---|---|
| N = 177,797 | (%) | N = 177,797 | (%) | |
| Gender | ||||
| Male | 15,731 | (8.8) | 15,731 | (8.8) |
| Female | 162,066 | (91.2) | 162,066 | (91.2) |
| Age (Mean ± SD) | 64.5 ± 11.5 | 64.5 ± 11.5 | ||
| <65 | 83,195 | (46.8) | 83,195 | (46.8) |
| ≥65 | 94,602 | (53.2) | 94,602 | (53.2) |
| Follow-up years (mean ± SD) | 8.8 ± 2.5 | 8.7 ± 2.8 | ||
| Income (mean ± SD) | 11.3 ± 7.1 | 11.3 ± 7.0 | ||
| Lowest | 48,619 | (27.3) | 48,619 | (27.3) |
| Lower mid | 23,060 | (13.0) | 23,060 | (13.0) |
| Upper mid | 36,904 | (20.8) | 36,904 | (20.8) |
| Highest | 69,214 | (38.9) | 69,214 | (38.9) |
| Urbanization level | ||||
| Metropolis | 82,863 | (46.6) | 82,863 | (46.6) |
| Urban | 75,475 | (42.5) | 75,475 | (42.5) |
| Rural | 19,459 | (10.9) | 19,459 | (10.9) |
| Diabetes | ||||
| Yes | 17,912 | (10.1) | 17,912 | (10.1) |
| No | 159,885 | (89.9) | 159,885 | (89.9) |
| Hypertension | ||||
| Yes | 89,122 | (50.1) | 89,122 | (50.1) |
| No | 88,675 | (49.9) | 88,675 | (49.9) |
| BPPV | ||||
| Yes | 4,964 | (2.8) | 2,801 | (1.6) |
| No | 172,833 | (97.2) | 174,996 | (98.4) |
| Recurrence of BPPV | ||||
| Yes | 876 | (17.6) | 437 | (15.6) |
| No | 4,089 | (82.4) | 2,364 | (84.4) |